Totally Baldacious: Shave One for the Team

Show your love and solidarity with cancer patients this Valentine's Day. Be baldacious by shaving or coloring your hair as a show of support for The Leukemia & Lymphoma Society's life-saving cancer research, and to show empathy with cancer patients who lose their hair from chemotherapy treatments. That's the concept behind "Totally Baldacious" an exciting new fundraising campaign of The Leukemia & Lymphoma Society (LLS).

Totally Baldacious launches on February 8. At www.totallybaldacious.org individuals will be able to set up a fundraising page for themselves or a team. Each individual who registers will receive a Totally Baldacious temporary tattoo. Individuals that raise $250 or more will receive a logo'd knit cap.

Much of this campaign will be promoted through social networking, and there will be a Totally Baldacious Fan Page on Facebook and a Totally Baldacious Twitter account. A "Be Baldacious" widget was designed to increase awareness virally. With the widget, users will be able to upload a photo of themselves and share their bald selves with friends.

The campaign is building momentum through different publicity efforts, including involvement of performing artist and leukemia survivor Kristine W., actor and leukemia survivor Evan Handler, a team of current and retired football stars, and the national FarmHouse Fraternity. In addition, the Town of Shavertown, PA, has agreed to hold a Totally Baldacious celebration involving the whole community.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap